Skip to main content
SpringerLink
Log in

Solitary Thyroid Nodule

  • Chapter
  • First Online:
Thyroid Disease

  • 1292 Accesses

Abstract

A thyroid nodule is a “discrete lesion within the thyroid gland that is radiologically distinct from the surrounding thyroid parenchyma.” A non-palpable nodule detected on ultrasound or other anatomical imaging studies is termed “incidentaloma.” A solitary thyroid nodule may represent a multitude of thyroid disorders. Currently, a variety of serological and cytogenetic tests, diagnostic imaging studies, and histopathological techniques exist for the evaluation of a thyroid nodule. This chapter addresses the prevalence, pathological classification, and initial clinical evaluation of a solitary thyroid nodule. It discusses the laboratory tests, imaging studies, and histological methods required to reach an accurate diagnosis. It also discusses and clarifies the challenges and debates concerning the management of this clinical entity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hurtado-Lopez LM, Arellano-Montano S, Torres-Acosta EM, et al. Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur J Nucl Med Mol Imaging. 2004;31:1273–9.

    PubMed  Google Scholar 

  2. Baskin HJ. Ultrasound of thyroid nodules. In: Baskin HJ, editor. Thyroid ultrasound and ultrasound-guided fna biopsy. Boston: Kluwer Academic; 2000. p. 71–86.

    Google Scholar 

  3. Keh SM, El-Shunnar SK, Palmer T, Ahsan SF. Incidence of malignancy in solitary thyroid nodules. J Laryngol Otol. 2015;129(7):677–81.

    CAS  PubMed  Google Scholar 

  4. Hanley P, Lord K, Bauer AJ. Thyroid disorders in children and adolescents: a review. JAMA Pediatr. 2016;170(10):1008–19.

    PubMed  Google Scholar 

  5. Hung W. Solitary thyroid nodules in 93 children and adolescents. A 35-year experience. Horm Res. 1999;52(1):15–8.

    CAS  PubMed  Google Scholar 

  6. Yip FW, Reeve TS, Poole AG. Thyroid nodules in childhood and adolescence. Aust N Z J Surg. 1994;64(10):676–8.

    CAS  PubMed  Google Scholar 

  7. Hung W, Anderson KD, Chandra RS, et al. Solitary thyroid nodules in 71 children and adolescents. J Pediatr Surg. 1992;27(11):1407–9.

    CAS  PubMed  Google Scholar 

  8. Stezhko VA, Buglova EE, Danilova LI. A cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident: objectives, design and methods. Radiat Res. 2004;161(4):481–92.

    CAS  PubMed  Google Scholar 

  9. Takahashi T, Fujimori K, Simon SL. Thyroid nodules, thyroid function and dietary iodine in the Marshall Islands. Int J Epidemiol. 1999;28(4):742–9.

    CAS  PubMed  Google Scholar 

  10. Chiesa F. Thyroid disease in Northern Italian children born around the time of the Chernobyl nuclear accident. Ann Oncol. 2004;15:1842–6.

    CAS  PubMed  Google Scholar 

  11. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338:296–7.

    Google Scholar 

  12. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96.

    PubMed  Google Scholar 

  13. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985;55:805–28.

    CAS  PubMed  Google Scholar 

  14. Rosai J, Carcangiu ML, Delellis RA. Tumours of the thyroid gland. In: Atlas of tumour pathology, 3rd series. Armed Forces of Institute of Pathology. Washington, DC: Wiley; 1992. p. 243.

    Google Scholar 

  15. Chan JK, Saw D. The grooved nucleus. A useful diagnostic criterion of papillary carcinoma of the thyroid. Am J Surg Pathol. 1986;10:672–9.

    CAS  PubMed  Google Scholar 

  16. Deligeorgi-Politi H. Nuclear crease as a cytodiagnostic feature of papillary thyroid carcinoma in fine-needle aspiration biopsies. Diagn Cytopathol. 1987;3:307–10.

    CAS  PubMed  Google Scholar 

  17. Scopa CD, Melachrinou M, Saradopoulou C, Merino MJ. The significance of the grooved nucleus in thyroid lesions. Mod Pathol. 1993;6:691–4.

    CAS  PubMed  Google Scholar 

  18. Gray A, Doniach I. Morphology of the nuclei of papillary carcinoma of the thyroid. Br J Cancer. 1969;23(1):49–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Johannessen JV, Gould VE, Jao W. The fine structure of human thyroid cancer. Hum Pathol. 1978;9(4):385–400.

    CAS  PubMed  Google Scholar 

  20. Lee TK, Myers RT, Marshall RB, Bond MG, Kardon B. The significance of mitotic rate: a retrospective study of 127 thyroid carcinomas. Hum Pathol. 1985;16(10):1042–6.

    CAS  PubMed  Google Scholar 

  21. Patchefsky AS, Hoch WS. Psammoma bodies in diffuse toxic goiter. Am J Clin Pathol. 1972;57(5):551–6.

    CAS  PubMed  Google Scholar 

  22. Chan JK, Tse CC. Mucin production in metastatic papillary carcinoma of the thyroid. Hum Pathol. 1988;19(2):195–200.

    CAS  PubMed  Google Scholar 

  23. Johannessen JV, Sobrinho-Simoes M. The origin and significance of thyroid psammoma bodies. Lab Invest. 1980;43(3):287–96.

    CAS  PubMed  Google Scholar 

  24. Selzer G, Kahn LB, Albertyn L. Primary malignant tumors of the thyroid gland: a clinicopathologic study of 254 cases. Cancer. 1977;40(4):1501–10.

    CAS  PubMed  Google Scholar 

  25. Katoh R, Sasaki J, Kurihara H, Suzuki K, Iida Y, Kawaoi A. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer. 1992;70(6):1585–90.

    CAS  PubMed  Google Scholar 

  26. Russell WO, Ibanez ML, Clark RL, White EC. Thyroid carcinoma. Classification, intraglandular dissemination, and clinicopathological study based upon whole organ sections of 80 glands. Cancer. 1963;16:1425–60.

    CAS  PubMed  Google Scholar 

  27. LiVolsi VA. Surgical pathology of the thyroid. In: Bennington JL, editor. Major problems in pathology, vol. 22. Philadelphia: WB Saunders; 1990. p. 136–72.

    Google Scholar 

  28. LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol. 2004;11(6):279–87.

    PubMed  Google Scholar 

  29. Williams ED. Guest editorial: two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol. 2000;8(3):181–3.

    PubMed  Google Scholar 

  30. Carcangiu ML. Minimally invasive follicular carcinoma. Endocr Pathol. 1997;8(3):231–4.

    PubMed  Google Scholar 

  31. Kahn NF, Perzin KH. Follicular carcinoma of the thyroid: an evaluation of the histologic criteria used for diagnosis. Pathol Annu. 1983;18(1):221–53.

    PubMed  Google Scholar 

  32. Pisanu A, Di Chiara B, Reccia I, Uccheddu A. Oncocytic cell tumors of the thyroid: factors predicting malignancy and influencing prognosis, treatment decisions, and outcomes. World J Surg. 2010;34(4):836–43.

    PubMed  Google Scholar 

  33. Lee KH, Shin JH, Ko ES, et al. Predictive factors of malignancy in patients with cytologically suspicious for Hurthle cell neoplasm of thyroid nodules. Int J Surg. 2013;11(9):898–902.

    PubMed  Google Scholar 

  34. Zhang YW, Greenblatt DY, Repplinger D, et al. Factors that predict malignancy in Hürthle cell neoplasms of the thyroid. J Surg Res. 2008;144(2):371–2.

    Google Scholar 

  35. Mills SC, Haq M, Smellie WJ, Harmer C. Hurthle cell carcinoma of the thyroid: retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003. Eur J Surg Oncol. 2009;35(3):230–4.

    CAS  PubMed  Google Scholar 

  36. Stojadinovic A, Ghossein RA, Hoos A, et al. Hurthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol. 2001;19(10):2616–25.

    CAS  PubMed  Google Scholar 

  37. Wakely PE Jr. Oncocytic and oncocyte-like lesions of the head and neck. Ann Diagn Pathol. 2008;12(3):222–30.

    PubMed  Google Scholar 

  38. Gonzalez-Campora R, Herrero-Zapatero A, Lerma E, Sanchez F, Galera H. Hurthle cell and mitochondrion-rich cell tumors. A clinicopathologic study. Cancer. 1986;57(6):1154–63.

    CAS  PubMed  Google Scholar 

  39. Baloch ZW, LiVolsi VA. Oncocytic lesions of the neuroendocrine system. Semin Diagn Pathol. 1999;16(2):190–9.

    CAS  PubMed  Google Scholar 

  40. Chen H, Udelsman R. Hürthle cell adenoma and carcinoma. In: Clark OH, Duh QY, editors. Textbook of endocrine surgery. 1st ed. Philadelphia: WB Saunders; 1997. p. 103–7.

    Google Scholar 

  41. Goldman ND, Coniglio JU, Falk SA. Thyroid cancers I: papillary, follicular, and Hürthle cell. Otolaryngol Clin North Am. 1996;30:593–609.

    Google Scholar 

  42. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159–65.

    PubMed  Google Scholar 

  43. Roh MH, Jo VY, Stelow EB, et al. The predictive value of the fine-needle aspiration diagnosis “suspicious for a FNHCT” in patients with Hashimoto thyroiditis. Am J Clin Pathol. 2012;120:73–86.

    Google Scholar 

  44. Stankov K, Romeo G. Oxyphilic carcinoma of the thyroid gland. Arch Oncol. 2003;11(2):81–9.

    Google Scholar 

  45. Melck A, Bugis S, Baliski C, et al. Hemithyroidectomy: the preferred initial surgical approach for management of Hurthle cell neoplasm. Am J Surg. 2006;191(5):593–7.

    CAS  PubMed  Google Scholar 

  46. Chen H, Nicol TL, Zeiger MA, et al. Hurthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann Surg. 1998;227(4):542–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Pisanu A, Sias L, Uccheddu A. Factors predicting malignancy of Hürthle cell tumors of the thyroid: influence on surgical treatment. World J Surg. 2004;28(8):761–5.

    PubMed  Google Scholar 

  48. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133.

    PubMed  PubMed Central  Google Scholar 

  49. Pu RT, Yang J, Wasserman PG, et al. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn Cytopathol. 2006;34(5):330–4.

    PubMed  Google Scholar 

  50. Danese D, Sciacchitano S, Farsetti A, et al. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid. 1998;8:15–21.

    CAS  PubMed  Google Scholar 

  51. Cohen EG, Shaha AR, Rinaldo A, Devaney KO, Ferlito A. Medullary thyroid carcinoma. Acta Otolaryngol. 2004;124(5):544–57.

    PubMed  Google Scholar 

  52. Abrosimov A. [Histologic and immunohistochemical characterization of medullary thyroid carcinoma]. Arkh Patol 1996;58(4):43–48.

    Google Scholar 

  53. Chang TC, Liaw KY, Kuo SH, Chang CC, Chen FW. Anaplastic thyroid carcinoma: review of 24 cases, with emphasis on cytodiagnosis and leukocytosis. Taiwan Yi Xue Hui Za Zhi. 1989;88(6):551–6.

    CAS  PubMed  Google Scholar 

  54. Berry B, MacFarlane J, Chan N. Osteoclastomalike anaplastic carcinoma of the thyroid. Diagnosis by fine needle aspiration cytology. Acta Cytol. 1990;34(2):248–50.

    CAS  PubMed  Google Scholar 

  55. Carcangiu M, Steeper T, Zampi G, et al. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol. 1985;83:135–58.

    CAS  PubMed  Google Scholar 

  56. Hurlimann J, Gardiol D, Scazziga B. Immunohistology of anaplastic thyroid carcinoma. Histopathology. 1987;11:567–72.

    CAS  PubMed  Google Scholar 

  57. Ito T, Seyama T, Mizuno T, et al. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res. 1992;52:1369–71.

    CAS  PubMed  Google Scholar 

  58. Dobashi Y, Sugimura H, Sakamoto A, et al. Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas. Diagn Mol Pathol. 1994;3:9–14.

    CAS  PubMed  Google Scholar 

  59. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. Cancer. 1983;52:1849–55.

    CAS  PubMed  Google Scholar 

  60. Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31(8):1256–64.

    PubMed  Google Scholar 

  61. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma”. Am J Surg Pathol. 1984;8:655–68.

    CAS  PubMed  Google Scholar 

  62. Doria R, Jekel JF, Cooper DL. Thyroid lymphoma. The case for combined modality therapy. Cancer. 1994;73:200–6.

    CAS  PubMed  Google Scholar 

  63. Compagno J, Oertel JE. Malignant lymphoma and other lymphoproliferative disorders of the thyroid gland. A clinicopathologic study of 245 cases. Am J Clin Pathol. 1980;74:1–11.

    CAS  PubMed  Google Scholar 

  64. Samaan NA, Ordonez NG. Uncommon types of thyroid cancer. Endocrinol Metab Clin North Am. 1990;19:637–48.

    CAS  PubMed  Google Scholar 

  65. Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol. 2000;24:623–39.

    CAS  PubMed  Google Scholar 

  66. Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol. 1999;26:316–23.

    CAS  PubMed  Google Scholar 

  67. Pasieka JL. Hashimoto’s disease and thyroid lymphoma: role of the surgeon. World J Surg. 2000;24:966–70.

    CAS  PubMed  Google Scholar 

  68. Thieblemont C, Mayer A, Dumontet C, Barbier Y, Callet-Bauchu E, Felman P, Berger F, Ducottet X, Martin C, Salles G, Orgiazzi J, Coiffier B. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab. 2002;87:105–11.

    CAS  PubMed  Google Scholar 

  69. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601–4.

    CAS  PubMed  Google Scholar 

  70. Kossev P, Livolsi V. Lymphoid lesions of the thyroid: review in light of the revised European-American lymphoma classification and upcoming World Health Organization classification. Thyroid. 1999;9(12):1273–80.

    CAS  PubMed  Google Scholar 

  71. Matsuzuka F, Miyauchi A, Katayama S, Narabayashi I, Ikeda H, Kuma K, Sugawara M. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid. 1993;3:93–9.

    CAS  PubMed  Google Scholar 

  72. Cha C, Chen H, Westra WH, Udelsman R. Primary thyroid lymphoma: can the diagnosis be made solely by fine-needle aspiration? Ann Surg Oncol. 2002;9:298–302.

    PubMed  Google Scholar 

  73. Lam KY, Lo CY. Metastatic tumors of the thyroid gland: a study of 79 cases in Chinese patients. Arch Pathol Lab Med. 1998;122(1):37–41.

    CAS  PubMed  Google Scholar 

  74. Lin JD, Weng HF, Ho YS. Clinical and pathological characteristics of secondary thyroid cancer. Thyroid. 1988;8:149–53.

    Google Scholar 

  75. Michelow PM, Leiman G. Metastases to the thyroid gland: diagnosis by aspiration cytology [see comment]. Diagn Cytopathol. 1995;13:209–13.

    CAS  PubMed  Google Scholar 

  76. Watts NB. Carcinoma metastatic to the thyroid: prevalence and diagnosis by fine-needle aspiration cytology. Am J Med Sci. 1987;293:13–7.

    CAS  PubMed  Google Scholar 

  77. Nakhjavani MK, Gharib H, Goellner JR, van Heerden JA. Metastasis to the thyroid gland. A report of 43 cases. Cancer. 1997;79:574–8.

    CAS  PubMed  Google Scholar 

  78. Rosen IB, Walfish PG, Bain J, Bedard YC. Secondary malignancy of the thyroid gland and its management. Ann Surg Oncol. 1995;2:252–6.

    CAS  PubMed  Google Scholar 

  79. Becker WF. Pioneers in thyroid surgery. Ann Surg. 1977;185(5):493–504.

    CAS  PubMed  PubMed Central  Google Scholar 

  80. Muller PE, Jakoby R, Heinert G, et al. Surgery for recurrent goitre: its complications and their risk factors. Eur J Surg. 2001;167:816–21.

    CAS  PubMed  Google Scholar 

  81. Campbell JP, Pillsbury HC III. Management of the thyroid nodule. Head Neck. 1989;11:414–25.

    CAS  PubMed  Google Scholar 

  82. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer. 2003;97:90–6.

    PubMed  Google Scholar 

  83. Fowler CL, Pokorny WJ, Harberg FJ. Thyroid nodules in children: current profile of a changing disease. South Med J. 1989;82(12):1472–8.

    CAS  PubMed  Google Scholar 

  84. Uyar O, Cetin B, Aksel B, et al. Malignancy in solitary thyroid nodules: evaluation of risk factors. Oncol Res Treat. 2017;40(6):360–3.

    PubMed  Google Scholar 

  85. Bouhabel S, Payne RJ, Mlynarek A, Hier M, Caglar D, Tamilia M. Are solitary thyroid nodules more likely to be malignant? J Otolaryngol Head Neck Surg. 2012;41(2):119–23.

    PubMed  Google Scholar 

  86. DeAndrade MA. A review of 128 cases of posterior mediastinal goiter. World J Surg. 1977;1(6):789–97.

    CAS  Google Scholar 

  87. Chami R, Moreno-Reyes R, Corvilain B. TSH measurement is not an appropriate screening test for autonomous functioning thyroid nodules: a retrospective study of 368 patients. Eur J Endocrinol. 2014;170(4):593–9.

    CAS  PubMed  Google Scholar 

  88. Asteria C, Giovanardi A, Pizzocaro A, et al. USelastography in the differential diagnosis of benign and malignant thyroid nodules. Thyroid. 2008;18:523–31.

    PubMed  Google Scholar 

  89. Tranquart F, Bleuzen A, Pierre-Renoult P, Chabrolle C, Sam Giao M, Lecomte P. Elastosonography of thyroid lesions [article in French]. J Radiol. 2008;89:35–9.

    CAS  PubMed  Google Scholar 

  90. Rago T, Santini F, Scutari M, Pinchera A, Vitti P. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab. 2007;92:2917–22.

    CAS  PubMed  Google Scholar 

  91. Cosgrove D. Future prospects for SonoVue and CPS. Eur Radiol. 2004;14(Suppl. 8):116–24.

    Google Scholar 

  92. Papini E, Bizzarri G, Pacella CM. Percutaneous laser ablation of benign and malignant thyroid nodules. Curr Opin Endocrinol Diabetes Obes. 2008;15:434–9.

    PubMed  Google Scholar 

  93. Weber AL, Randolph G, Aksoy FG. The thyroid and parathyroid glands: CT and MR imaging and correlation with pathology and clinical findings. Radiol Clin North Am. 2000;38:1105–29.

    CAS  PubMed  Google Scholar 

  94. Wu HH, Jones JN, Osman J. Fine-needle aspiration cytology of the thyroid: ten years experience in a community teaching hospital. Diagn Cytopathol. 2006;34:93–6.

    PubMed  Google Scholar 

  95. Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007;111:306–15.

    PubMed  Google Scholar 

  96. Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid. 1998;8:15–21.

    CAS  PubMed  Google Scholar 

  97. Kihara M, Hirokawa M, Masuoka H, Yabuta T, Shindo H, Higashiyama T, et al. Evaluation of cytologically benign solitary thyroid nodules by ultrasonography: a retrospective analysis of 1877 cases. Auris Nasus Larynx. 2013;40(3):308–11.

    PubMed  Google Scholar 

  98. Papini E. The dilemma of non-palpable thyroid nodules. J Endocrinol Invest. 2003;26:3–4.

    CAS  PubMed  Google Scholar 

  99. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B. Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab. 1997;82:1589–93.

    CAS  PubMed  Google Scholar 

  100. Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab. 2008;93:2173–80.

    CAS  PubMed  Google Scholar 

  101. Kotzmann H, Schmidt A, Scheuba C, et al. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma. Thyroid. 1999;9:943–7.

    CAS  PubMed  Google Scholar 

  102. Mehanna HM, Jain A, Morton RP, Watkinson J, Shaha A. Investigating the thyroid nodule. BMJ. 2009;338:705–9.

    Google Scholar 

  103. Cantisani V, Catania A, De Antoni E, Greco R, Caruso R, Di Segni M, et al. Is pattern III as evidenced by US color-Doppler useful in predicting thyroid nodule malignancy? Large-scale retrospective analysis. Clin Ter. 2010;161(2):e49–52.

    CAS  PubMed  Google Scholar 

  104. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, et al. Risk of malignancy in non-palpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002;87(5):1941–6.

    CAS  PubMed  Google Scholar 

  105. Fish SA, Langer JE, Mandel SJ. Sonographic imaging of thyroid nodules and cervical lymph nodes. Endocrinol Metab Clin North Am. 2008;37(2):401–17.

    PubMed  Google Scholar 

  106. Zada B, Anwar K, Malik SA, Niamatullah, Khan N, Salam F. Anatomical relationship between recurrent laryngeal nerve and inferior thyroid artery in thyroidectomy patients. J Ayub Med Coll Abbottabad. 2014;26(3):380–3.

    PubMed  Google Scholar 

  107. Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med. 1993;13:699–709.

    CAS  PubMed  Google Scholar 

  108. Cersosimo E, Gharib H, Suman VJ, Goellner JR. “Suspicious” thyroid cytologic findings: outcome in patients without immediate surgical treatment. Mayo Clin Proc. 1993;68:343–8.

    CAS  PubMed  Google Scholar 

  109. Yuan Z, Quan J, Yunxiao Z, Jian C, Zhu H. Contrast-enhanced ultrasound in the diagnosis of solitary thyroid nodules. J Cancer Res Ther. 2015;11(1):41–5.

    PubMed  Google Scholar 

  110. Can AS, Peker K. Comparison of palpation-versus ultrasound-guided fine-needle aspiration biopsies in the evaluation of thyroid nodules. BMC Res Notes. 2008;1:12–7.

    PubMed  PubMed Central  Google Scholar 

  111. Goldfarb M, Gondek S, Solorzano C, Lew JI. Surgeon-performed ultrasound can predict benignity in thyroid nodules. Surgery. 2011;150(3):436–41.

    PubMed  Google Scholar 

  112. Hegde A, Gopinathan A, Abu Bakar R, Ooi CC, Koh YY, Lo RH. A method in the madness in ultrasound evaluation of thyroid nodules. Singapore Med J. 2012;53(11):766–72.

    PubMed  Google Scholar 

  113. Gharib H, Goellner JR. Fine-needle aspiration biopsy of thyroid nodules. Endocr Pract. 1995;1:410–7.

    CAS  PubMed  Google Scholar 

  114. Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36:425–37.

    PubMed  Google Scholar 

  115. Hamilton JG, Soley MH. Studies in iodine metabolism by use of a new radioactive isotope of iodine. Am J Physiol. 1939;127:557–61.

    CAS  Google Scholar 

  116. Choudhury M, Singh S, Agarwal S. Diagnostic utility of Ki67 and p53 immunostaining on solitary thyroid nodule--a cytohistological and radionuclide scintigraphic study. Indian J Pathol Microbiol. 2011;54(3):472–5.

    PubMed  Google Scholar 

  117. Price DC. Radioisotopic evaluation of the thyroid and the parathyroids. Radiol Clin North Am. 1993;31(5):991–1015.

    CAS  PubMed  Google Scholar 

  118. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Invest. 2010;3(5 Suppl):1–6.

    Google Scholar 

  119. Bonnema SJ, Bennedbaek FN, Hegedus L. Danish endocrinologists’ examination and treatment of non-toxic multinodular goiter: a questionnaire study [article in Danish]. Ugeskr Laeger. 2001;163:1265–9.

    CAS  PubMed  Google Scholar 

  120. Hillenhinrichs H, Emrich D. Euthyroid goiter with and without functional autonomy in the euthyroid phase: a comparison [article in German]. Nuklearmedizin. 1998;37:95–100.

    CAS  PubMed  Google Scholar 

  121. Tollin SR, Fallon EF, Mikhail M, Goldstein H, Yung E. The utility of thyroid nuclear imaging and other studies in the detection and treatment of underlying thyroid abnormalities in patients with endogenous subclinical thyrotoxicosis. Clin Nucl Med. 2000;25:341–7.

    CAS  PubMed  Google Scholar 

  122. Krohn K, Wohlgemuth S, Gerber H, Paschke R. Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations. J Pathol. 2000;192:37–42.

    CAS  PubMed  Google Scholar 

  123. Nagai GR, Pitts WC, Basso L, Cisco JA, McDougall IR. Scintigraphic hot nodules and thyroid carcinoma. Clin Nucl Med. 1987;12:123–7.

    CAS  PubMed  Google Scholar 

  124. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126(3):226–31.

    CAS  PubMed  Google Scholar 

  125. Wu CW, Dionigi G, Lee KW, Hsiao PJ, Paul Shin MC, Tsai KB, et al. Calcifications in thyroid nodules identified on preoperative computed tomography: patterns and clinical significance. Surgery. 2011;10:12–9.

    Google Scholar 

  126. Deandrea M, Mormile A, Veglio M, et al. Fine-needle aspiration biopsy of the thyroid: comparison between thyroid palpation and ultrasonography. Endocr Pract. 2002;8:282–6.

    PubMed  Google Scholar 

  127. Beech P, Lavender I, Jong I, Soo G, Ramdave S, Chong A, Nandurkar D. Ultrasound stratification of the FDG-avid thyroid nodule. Clin Radiol. 2016;71:164–9.

    CAS  PubMed  Google Scholar 

  128. Basharat R, Bukhari MH, Saeed S, Hamid T. Comparison of fine needle aspiration cytology and thyroid scan in solitary thyroid nodule. Pathol Res Int. 2011;2011:754041.

    Google Scholar 

  129. Yip L, Farris C, Kabaker AS, Hodak SP, Nikiforova MN, McCoy KL, et al. Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. J Clin Endocrinol Metab. 2012;97(6):1905–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  130. Thomusch O, Machens A, Sekulla C, Ukkat J, Lippert H, Gastinger I, Dralle H. Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg. 2000;24:1335–41.

    CAS  PubMed  Google Scholar 

  131. Al-Shaikh A, Ngan B, Daneman A, Daneman D. Fine-needle aspiration biopsy in the management of thyroid nodules in children and adolescents. J Pediatr. 2001;138(1):140–2.

    CAS  PubMed  Google Scholar 

  132. Lugo-Vicente H, Ortiz VN, Irizarry H, et al. Pediatric thyroid nodules: management in the era of fine needle aspiration. J Pediatr Surg. 1998;33(8):1302–5.

    CAS  PubMed  Google Scholar 

  133. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab. 2004;89(1):163–8.

    CAS  PubMed  Google Scholar 

  134. Fadda G, Basolo F, Bondi A, Bussolati G, Crescenzi A, Nappi O, Nardi F, Papotti M, Taddei G, Palombini L, SIAPEC-IAP Italian Consensus Working Group. Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian Consensus Working Group. Pathologica. 2010;102(5):405–8.

    CAS  PubMed  Google Scholar 

  135. Wohllk N, Cote GJ, Bugalho MM, et al. Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab. 1996;81:3740–5.

    CAS  PubMed  Google Scholar 

  136. Kwak MJ, Son EJ, Moon HJ. How to combine ultrasound and cytological information in decision making about thyroid nodules. Eur Radiol. 2009;19:1923–31.

    PubMed  Google Scholar 

  137. McHenry CR, Walfish PG, Rosen IB. Non-diagnostic fine needle aspiration biopsy: a dilemma in management of nodular thyroid disease. Am Surg. 1993;59:415–9.

    CAS  PubMed  Google Scholar 

  138. Schmidt T, Riggs MW, Speights VO Jr. Significance of nondiagnostic fine-needle aspiration of the thyroid. South Med J. 1997;90:1183–6.

    CAS  PubMed  Google Scholar 

  139. MacDonald L, Yazdi HM. Nondiagnostic fine needle aspiration biopsy of the thyroid gland: a diagnostic dilemma. Acta Cytol. 1996;40:423–8.

    CAS  PubMed  Google Scholar 

  140. Cappelli C, Pirola I, Castellano M, et al. Fine needle cytology of complex thyroid nodules. Eur J Endocrinol. 2007;157:529–32.

    CAS  PubMed  Google Scholar 

  141. Orlandi A, Puscar A, Capriata E, Fideleff H. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up. Thyroid. 2005;15:274–8.

    CAS  PubMed  Google Scholar 

  142. La Rosa GL, Belfiore A, Giuffrida D, et al. Evaluation of the fine needle aspiration biopsy in the preoperative selection of cold thyroid nodules. Cancer. 1991;67:2137–41.

    PubMed  Google Scholar 

  143. Slowinska-Klencka D, Klencki M, Sporny S, Lewinski A. Fine-needle aspiration biopsy of the thyroid in an area of endemic goitre: influence of restored sufficient iodine supplementation on the clinical significance of cytological results. Eur J Endocrinol. 2002;146:19–26.

    CAS  PubMed  Google Scholar 

  144. Gallo M, Pesenti M, Valcavi R. Ultrasound thyroid nodule measurements: the “gold standard” and its limitations in clinical decision making. Endocr Pract. 2003;9:194–9.

    PubMed  Google Scholar 

  145. Menendez Torre E, Pineda Arribas J, Martinez de Esteban JP, et al. Value of repeated fine needle aspiration cytology in patients with nodular goiter. Acta Cytol. 2007;51:850–2.

    PubMed  Google Scholar 

  146. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study. N Engl J Med. 1987;317:70–5.

    CAS  PubMed  Google Scholar 

  147. La Rosa GL, Ippolito AM, Lupo L, et al. Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics. J Clin Endocrinol Metab. 1996;81:4385–7.

    PubMed  Google Scholar 

  148. Papini E, Petrucci L, Guglielmi R, et al. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab. 1998;83:780–3.

    CAS  PubMed  Google Scholar 

  149. Wemeau JL, Caron P, Schvartz C, et al. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab. 2002;87:4928–34.

    CAS  PubMed  Google Scholar 

  150. Hegedus L, Nygaard B, Hansen JM. Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified? J Clin Endocrinol Metab. 1999;84:756–60.

    CAS  PubMed  Google Scholar 

  151. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol. 1994;130:350–6.

    CAS  PubMed  Google Scholar 

  152. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–52.

    CAS  PubMed  Google Scholar 

  153. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001;358:861–5.

    CAS  PubMed  Google Scholar 

  154. La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med. 1995;122:1–8.

    PubMed  Google Scholar 

  155. Miccoli P, Minuto MN, Ugolini C, Pisano R, Fosso A, Berti P. Minimally invasive video-assisted thyroidectomy for benign thyroid disease: an evidence-based review. World J Surg. 2008;32:1333–40.

    PubMed  Google Scholar 

  156. Alvarado R, McMullen T, Sidhu SB, Delbridge LW, Sywak MS. Minimally invasive thyroid surgery for single nodules: an evidence-based review of the lateral mini-incision technique. World J Surg. 2008;32:1341–8.

    PubMed  Google Scholar 

  157. Livraghi T, Paracchi A, Ferrari C, et al. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results: work in progress. Radiology. 1990;175:827–9.

    CAS  PubMed  Google Scholar 

  158. Pacella CM, Bizzarri G, Guglielmi R, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation: a feasibility study. Radiology. 2000;217:673–7.

    CAS  PubMed  Google Scholar 

  159. Verde G, Papini E, Pacella CM, et al. Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules. Clin Endocrinol (Oxf). 1994;41:719–24.

    CAS  Google Scholar 

  160. Guglielmi R, Pacella CM, Bianchini A, et al. Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid. 2004;14:125–31.

    CAS  PubMed  Google Scholar 

  161. Valcavi R, Frasoldati A. Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocr Pract. 2004;10:269–75.

    PubMed  Google Scholar 

  162. Kim JH, Lee HK, Lee JH, Ahn IM, Choi CG. Efficacy of sonographically guided percutaneous ethanol injection for treatment of thyroid cysts versus solid thyroid nodules. AJR Am J Roentgenol. 2003;180:1723–6.

    PubMed  Google Scholar 

  163. Zingrillo M, Torlontano M, Chiarella R, et al. Percutaneous ethanol injection may be a definitive treatment for symptomatic thyroid cystic nodules not treatable by surgery: five-year follow-up study. Thyroid. 1999;9:763–7.

    CAS  PubMed  Google Scholar 

  164. Bennedbaek FN, Hegedus L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab. 2003;88:5773–7.

    CAS  PubMed  Google Scholar 

  165. McHenry CR, Slusarczyk SJ, Askari AT, et al. Refined use of scintigraphy in the evaluation of nodular thyroid disease. Surgery. 1998;124:656–61.

    CAS  PubMed  Google Scholar 

  166. Freudenberg LS, Antoch G, Jentzen W, et al. Value of (124) I-PET/CT in staging of patients with differentiated thyroid cancer. Eur Radiol. 2004;14:2092–8.

    CAS  PubMed  Google Scholar 

  167. Moosa M, Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab. 1997;82:2862–6.

    CAS  PubMed  Google Scholar 

  168. Rallison ML, Dobyns BM, Keating FR Jr, Rall JE, Tyler FH. Thyroid nodularity in children. JAMA. 1975;233:1069–72.

    CAS  PubMed  Google Scholar 

  169. Bonnema SJ, Bennedbaek FN, Veje A, Marving J, Hegedus L. Propylthiouracil before 131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial. J Clin Endocrinol Metab. 2004;89:4439–44.

    CAS  PubMed  Google Scholar 

  170. Hegedus L, Hansen BM, Knudsen N, Hansen JM. Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. BMJ. 1988;297:661–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  171. Raab SS, Silverman JF, Elsheikh TM, Thomas PA, Wakely PE. Pediatric thyroid nodules: disease demographics and clinical management as determined by fine needle aspiration biopsy. Pediatrics. 1995;95:46–9.

    CAS  PubMed  Google Scholar 

  172. Amrikachi M, Ponder TB, Wheeler TM, Smith D, Ramzy I. Thyroid fine-needle aspiration biopsy in children and adolescents: experience with 218 aspirates. Diagn Cytopathol. 2005;32:189–92.

    PubMed  Google Scholar 

  173. Chang SH, Joo M, Kim H. Fine needle aspiration biopsy of thyroid nodules in children and adolescents. J Korean Med Sci. 2006;21:469–73.

    PubMed  PubMed Central  Google Scholar 

  174. Belfiore A, La Rosa GL, Padova G, Sava L, Ippolito O, Vigneri R. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer. 1987;60:3096–102.

    CAS  PubMed  Google Scholar 

  175. Canadian Pediatric Thyroid Nodule (CaPTN) Study Group. The Canadian Pediatric Thyroid Nodule Study: an evaluation of current management practices. J Pediatr Surg. 2008;43:826–30.

    Google Scholar 

  176. Deandreis D, Al Ghuzlan A, Auperin A, Vielh P, Caillou B, Chami L, Lumbroso J, Travagli JP, Hartl D, Baudin E, Schlumberger M, Leboulleux S. Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid. 2012;22:165–72.

    CAS  PubMed  Google Scholar 

  177. Stojadinovic A, Peoples GE, Libutti SK, Henry LR, Eberhardt J, Howard RS, Gur D, Elster EA, Nissan A. Development of a clinical decision model for thyroid nodules. BMC Surg. 2009;9:12–7.

    PubMed  PubMed Central  Google Scholar 

  178. Tuttle RM, Lemar H, Burch HB. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid. 1998;8:377–83.

    CAS  PubMed  Google Scholar 

  179. Goldstein RE, Netterville JL, Burkey B, Johnson JE. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg. 2002;235:656–62.

    PubMed  PubMed Central  Google Scholar 

  180. Schlinkert RT, van Heerden JA, Goellner JR, Gharib H, Smith SL, Rosales RF, Weaver AL. Factors that predict malignant thyroid lesions when fine-needle aspiration is “suspicious for follicular neoplasm”. Mayo Clin Proc. 1997;72:913–6.

    CAS  PubMed  Google Scholar 

  181. Mehta RS, Carty SE, Ohori NP, Hodak SP, Coyne C, LeBeau SO, Tublin ME, Stang MT, Johnson JT, McCoy KL, Nikiforova MN, Nikiforov YE, Yip L. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology. Surgery. 2013;154:730–6.

    PubMed  Google Scholar 

  182. Corrias A, Einaudi S, Chiorboli E, et al. Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches. J Clin Endocrinol Metab. 2001;86:4644–8.

    CAS  PubMed  Google Scholar 

  183. Gough J, Scott-Coombes D, Fausto PF. Thyroid incidentaloma: an evidence-based assessment of management strategy. World J Surg. 2008;32:1264–8.

    PubMed  Google Scholar 

  184. Christensen SB, Bondeson L, Ericsson UB, Lindholm K. Prediction of malignancy in the solitary thyroid nodule by physical examination, thyroid scan, fine-needle biopsy and serum thyroglobulin: a prospective study of 100 surgically treated patients. Acta Chir Scand. 1984;150:433–9.

    CAS  PubMed  Google Scholar 

  185. Hamburger JI, Husain M. Contribution of intraoperative pathology evaluation to surgical management of thyroid nodules. Endocrinol Metab Clin North Am. 1990;19:509–22.

    CAS  PubMed  Google Scholar 

  186. Hamming JF, Goslings BM, van Steenis GJ, van Ravenswaay CH, Hermans J, van de Velde CJ. The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. Arch Intern Med. 1990;150:113–6.

    CAS  PubMed  Google Scholar 

  187. Drozd VM, Lushchik ML, Polyanskaya ON, et al. The usual ultrasonographic features of thyroid cancer are less frequent in small tumors that develop after a long latent period after the Chernobyl radiation release accident. Thyroid. 2009;19:725–34.

    PubMed  Google Scholar 

  188. Feinmesser R, Lubin E, Segal K, Noyek A. Carcinoma of the thyroid in children: A review. J Pediatr Endocrinol Metab. 1997;10:561–8.

    CAS  PubMed  Google Scholar 

  189. Kim E, Park JS, Son KR, Kim JH, Jeon SJ, Na DG. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid. 2008;18:411–8.

    CAS  PubMed  Google Scholar 

  190. Alessandri AJ, Goddard KJ, Blair GK, Fryer CJ, Schultz KR. Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Med Pediatr Oncol. 2000;35:41–6.

    CAS  PubMed  Google Scholar 

  191. Niedziela M, Breborowicz D, Trejster E, Korman E. Hot nodules in children and adolescents in western Poland from 1996 to 2000: clinical analysis of 31 patients. J Pediatr Endocrinol Metab. 2002;15:823–30.

    CAS  PubMed  Google Scholar 

  192. Haynes RB, Wilczynski N, McKibbon KA, Walker CJ, Sinclair JC. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J Am Med Inform Assoc. 1994;1:447–58.

    CAS  PubMed  PubMed Central  Google Scholar 

  193. Hunt DL, McKibbon KA. Locating and appraising systematic reviews. Ann Intern Med. 1997;126:532–8.

    CAS  PubMed  Google Scholar 

  194. Walter MA, Briel M, Christ-Crain M, et al. Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. BMJ. 2007;334:514.

    CAS  PubMed  PubMed Central  Google Scholar 

  195. Lippi F, Ferrari C, Manetti L, et al; the Multicenter Study Group. Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. J Clin Endocrinol Metab. 1996;81:3261–4.

    Google Scholar 

  196. Livraghi T, Paracchi A, Ferrari C, Reschini E, Macchi RM, Bonifacino A. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: 4-year experience. Radiology. 1994;190:529–33.

    CAS  PubMed  Google Scholar 

  197. Cakir B, Ugras NS, Gul K, Ersoy R, Korukluoglu B. Initial report of the results of percutaneous laser ablation of benign cold thyroid nodules: evaluation of histopathological changes after 2 years. Endocr Pathol. 2009;20:170–6.

    PubMed  Google Scholar 

  198. Nygaard B, Hegedus L, Nielsen KG, Ulriksen P, Hansen JM. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol (Oxf). 1999;50:197–202.

    CAS  Google Scholar 

  199. Dietlein M, Dressler J, Grunwald F, et al. Deutsche Gesellschaft für Nuklearmedizin Guideline for radioiodine therapy for benign thyroid diseases (version 4) [article in German]. Nuklearmedizin. 2007;46:220–3.

    CAS  PubMed  Google Scholar 

  200. Renshaw AA, Pinnar N. Comparison of thyroid fine-needle aspiration and core needle biopsy. Am J Clin Pathol. 2007;128:370–4.

    PubMed  Google Scholar 

  201. Elsheikh TM, Singh HK, Silverman JF. Fine-needle aspiration cytology versus core needle biopsy in the evaluation of thyroid and salivary gland lesions. Pathol Case Rev. 2007;12:3–9.

    Google Scholar 

  202. Pisani T, Bononi M, Nagar C, Angelini M, Bezzi M, Vecchione A. Fine needle aspiration and core needle biopsy techniques in the diagnosis of nodular thyroid pathologies. Anticancer Res. 2000;20:3843–7.

    CAS  PubMed  Google Scholar 

  203. Loh KC, Greenspan FS, Gee L, et al. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab. 1997;82(11):3553–62.

    CAS  PubMed  Google Scholar 

  204. British Thyroid Association, Royal College of Physicians. British Thyroid Association Guidelines for the management of thyroid cancer. 2nd ed. London: Royal College of Physicians; 2007.

    Google Scholar 

  205. Lansford CD, Teknos TN. Evaluation of the thyroid nodule. Cancer Control. 2006;13(2):89–98.

    PubMed  Google Scholar 

  206. Datta RV, Petrelli NJ, Ramzy J. Evaluation and management of incidentally discovered thyroid nodules. Surg Oncol. 2006;15:33–42.

    PubMed  Google Scholar 

  207. Diamond T, Nery L, Hales I. A therapeutic dilemma: suppressive doses of thyroxine significantly red measurements in both premenopausal and postmenopausal women with thyroid cancer. J Clin Endocrinol Metab. 1991;72(6):1184–8.

    CAS  PubMed  Google Scholar 

  208. Oertel YC, Miyahara-Felipe L, Mendoza MG, Yu K. Value of repeated fine needle aspirations of the thyroid: an analysis of over ten thousand FNAs. Thyroid. 2007;17:1061–6.

    PubMed  Google Scholar 

  209. Erdogan MF, Kamel N, Aras D, Akdogan A, Baskal N, Erdogan G. Value of re-aspirations in benign nodular thyroid disease. Thyroid. 1998;8:1087–90.

    CAS  PubMed  Google Scholar 

  210. Illouz F, Rodien P, Saint-Andre JP, Triau S, Laboureau-Soares S, Dubois S, Vielle B, Hamy A, Rohmer V. Usefulness of repeated fine-needle cytology in the follow-up of non-operated thyroid nodules. Eur J Endocrinol. 2007;156:303–8.

    CAS  PubMed  Google Scholar 

  211. Tee YY, Lowe AJ, Brand CA, Judson RT. Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review. Ann Surg. 2007;246:714–20.

    PubMed  Google Scholar 

  212. Pinchot SN, Al-Wagih H, Schaefer S, Sippel R, Chen H. Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger. Arch Surg. 2009;144:649–55.

    PubMed  PubMed Central  Google Scholar 

  213. Kuru B, Gulcelik NE, Gulcelik MA, Dincer H. The false-negative rate of fine-needle aspiration cytology for diagnosing thyroid carcinoma in thyroid nodules. Langenbecks Arch Surg. 2010;395:127–32.

    PubMed  Google Scholar 

  214. Wharry LI, McCoy KL, Stang MT, Armstrong MJ, LeBeau SO, Tublin ME, Sholosh B, Silbermann A, Ohori NP, Nikiforov YE, Hodak SP, Carty SE, Yip L. Thyroid nodules (>/ = 4 cm): can ultrasound and cytology reliably exclude cancer? World J Surg. 2014;38:614–21.

    PubMed  Google Scholar 

  215. Yoon JH, Kwak JY, Moon HJ, Kim MJ, Kim EK. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger. Thyroid. 2011;21:993–1000.

    PubMed  Google Scholar 

  216. Porterfield JR Jr, Grant CS, Dean DS, Thompson GB, Farley DR, Richards ML, Reading CC, Charboneau JW, Vollrath BK, Sebo TJ. Reliability of benign fine needle aspiration cytology of large thyroid nodules. Surgery. 2008;144:963–8.

    PubMed  Google Scholar 

  217. Nou E, Kwong N, Alexander LK, Cibas ES, Marqusee E, Alexander EK. Determination of the optimal time interval for repeat evaluation after a benign thyroid nodule aspiration. J Clin Endocrinol Metab. 2014;99:510–6.

    CAS  PubMed  Google Scholar 

  218. Mazzaferri EL. Management of low-risk differentiated thyroid cancer. Endocr Pract. 2007;13:498–512.

    PubMed  Google Scholar 

  219. Hay ID. Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract. 2007;13:521–33.

    PubMed  Google Scholar 

  220. Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. 2010;34:1222–31.

    PubMed  Google Scholar 

  221. Yu XM, Wan Y, Sippel RS, Chen H. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg. 2011;254:653–60.

    PubMed  Google Scholar 

  222. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98:31–40.

    PubMed  Google Scholar 

  223. Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ, Goellner JR. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008;144:980–7.

    PubMed  Google Scholar 

  224. Roti E, Degli Uberti EC, Bondanelli M, Braverman LE. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol. 2008;159:659–73.

    CAS  PubMed  Google Scholar 

  225. Giordano D, Gradoni P, Oretti G, Molina E, Ferri T. Treatment and prognostic factors of papillary thyroid microcarcinoma. Clin Otolaryngol. 2010;35:118–24.

    CAS  PubMed  Google Scholar 

  226. Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, Tomoda C, Takamura Y, Kobayashi K, Miya A. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34:28–35.

    PubMed  Google Scholar 

  227. Niemeier LA, Kuffner AH, Song C, Carty SE, Hodak SP, Yip L, Ferris RL, Tseng GC, Seethala RR, LeBeau SO, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforov YE. A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer. 2012;118:2069–77.

    CAS  PubMed  Google Scholar 

  228. O’Brien T, Gharib H, Suman VJ, et al. Treatment of toxic solitary thyroid nodules: surgery versus radioactive iodine. Surgery. 1992;112:1166–70.

    PubMed  Google Scholar 

  229. Alexander EK, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, Marqusee E. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab. 2002;87:4924–7.

    CAS  PubMed  Google Scholar 

  230. Brito JP, Gionfriddo MR, Al NA, Boehmer KR, Leppin AL, Reading C, et al. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99:1253–63.

    CAS  PubMed  Google Scholar 

  231. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

    PubMed  Google Scholar 

  232. Chen YT, Kitabayashi N, Zhou XK, Fahey TJ III, Scognamiglio T. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol. 2008;21:1139–46.

    CAS  PubMed  Google Scholar 

  233. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab. 2008;93:1600–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  234. Colombo C, Verga U, Mian C, Ferrero S, Perrino M, Vicentini L, Dazzi D, Opocher G, Pelizzo MR, Beck-Peccoz P, Fugazzola L. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab. 2012;97:905–13.

    CAS  PubMed  Google Scholar 

  235. Orija IB, Pineyro M, Biscotti C, Reddy SS, Hamrahian AH. Value of repeating a nondiagnostic thyroid fine-needle aspiration biopsy. Endocr Pract. 2007;13:735–42.

    PubMed  Google Scholar 

  236. Mazeh H, Mizrahi I, Halle D, Ilyayev N, Stojadinovic A, Trink B, et al. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. Thyroid. 2011;21:111–8.

    CAS  PubMed  Google Scholar 

  237. Shen R, Liyanarachchi S, Li W, Wakely PE Jr, Saji M, Huang J, et al. MicroRNA signature in thyroid fine needle aspiration cytology applied to “atypia of undetermined significance” cases. Thyroid. 2012;22:9–16.

    CAS  PubMed  PubMed Central  Google Scholar 

  238. Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;25:716–59.

    PubMed  PubMed Central  Google Scholar 

  239. Hall TL, Layfield LJ, Philippe A, Rosenthal DL. Sources of diagnostic error in fine needle aspiration of the thyroid. Cancer. 1989;63:718–25.

    CAS  PubMed  Google Scholar 

  240. Nishimori H, Tabah R, Hickeson M, How J. Incidental thyroid “PETomas”: clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake. Can J Surg. 2011;54:83–8.

    PubMed  PubMed Central  Google Scholar 

  241. Keutgen XM, Filicori F, Crowley MJ, Wang Y, Scognamiglio T, Hoda R, et al. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res. 2012;18:2032–8.

    CAS  PubMed  Google Scholar 

  242. Gagel RF, Hoff AO, Cote GE. Medullary thyroid carcinoma. In: Braverman L, Utiger R, editors. Werner and Ingbar’s the thyroid. Philadelphia: Lippincott Williams and Wilkins; 2005. p. 967–88.

    Google Scholar 

  243. Agretti P, Ferrarini E, Rago T, Candelieri A, De Marco G, Dimida A, et al. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration. Eur J Endocrinol. 2012;167:393–400.

    CAS  PubMed  Google Scholar 

  244. Labourier E, Shifrin A, Busseniers AE, Lupo MA, Manganelli ML, Andruss B, et al. Molecular testing for miRNA, mRNA, and DNA on fine-needle aspiration improves the preoperative diagnosis of thyroid nodules with indeterminate cytology. J Clin Endocrinol Metab. 2015;100:2743–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  245. Milas M, Shin J, Gupta M, Novosel T, Nasr C, Brainard J, et al. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples. Ann Surg. 2010;252:643–51.

    PubMed  Google Scholar 

  246. McGovern MM, Benach MO, Wallenstein S, Desnick RJ, Keenlyside R. Quality assurance in molecular genetic testing laboratories. JAMA. 1999;281:835–40.

    CAS  PubMed  Google Scholar 

  247. McGovern MM, Elles R, Beretta I, Somerville MJ, Hoefler G, Keinanen M, et al. Report of an international survey of molecular genetic testing laboratories. Community Genet. 2007;10:123–31.

    PubMed  Google Scholar 

  248. Krane JF, Nayar R, Renshaw AA. Atypia of undetermined significance/follicular lesion of undetermined significance. In: Ali SZ, Cibas ES, editors. The Bethesda system for reporting thyroid cytopathology. Berlin: Springer; 2010. p. 37–49.

    Google Scholar 

  249. Bongiovanni M, Crippa S, Baloch Z, Piana S, Spitale A, Pagni F, Mazzucchelli L, Di BC, Faquin W. Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study. Cancer Cytopathol. 2012;20:117–25.

    Google Scholar 

  250. Davidov T, Trooskin SZ, Shanker BA, Yip D, Eng O, Crystal J, et al. Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy. Surgery. 2010;148:1294–9.

    PubMed  Google Scholar 

  251. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050–7.

    CAS  PubMed  Google Scholar 

  252. Shah MD, Hall FT, Eski SJ, Witterick IJ, Walfish PG, Freeman JL. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope. 2003;113:2102–7.

    PubMed  Google Scholar 

  253. Wang TS, Dubner S, Sznyter LA, Heller KS. Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes. Arch Otolaryngol Head Neck Surg. 2004;30:110–3.

    CAS  Google Scholar 

  254. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid. 1999;9:421–7.

    CAS  PubMed  Google Scholar 

  255. Mazzaferri EL. Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr Pract. 2000;6:469–76.

    CAS  PubMed  Google Scholar 

  256. Cooper DS, Specker B, Ho M, Sperling M, Ladenson PW, Ross DS, et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid. 1998;8:737–44.

    CAS  PubMed  Google Scholar 

  257. Lin JD, Chao TC, Huang MJ, Weng HF, Tzen KY. Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation. Am J Clin Oncol. 1998;21:77–81.

    CAS  PubMed  Google Scholar 

  258. Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O’Sullivan B. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example. Cancer. 1997;79:2414–23.

    CAS  PubMed  Google Scholar 

  259. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002;26:879–85.

    PubMed  Google Scholar 

  260. Gourin CG, Tufano RP, Forastiere AA, Koch WM, Pawlik TM, Bristow RE. Volume-based trends in thyroid surgery. Arch Otolaryngol Head Neck Surg. 2010;136:1191–8.

    PubMed  Google Scholar 

  261. Stavrakis AI, Ituarte PH, Ko CY, Yeh MW. Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. Surgery. 2007;142:887–99.

    PubMed  Google Scholar 

  262. Soh EY, Clark OH. Surgical considerations and approach to thyroid cancer. Endocrinol Metab Clin North Am. 1996;25:115–39.

    CAS  PubMed  Google Scholar 

  263. Reeve T, Thompson NW. Complications of thyroid surgery: how to avoid them, how to manage them, and observations on their possible effect on the whole patient. World J Surg. 2000;24:971–5.

    CAS  PubMed  Google Scholar 

  264. Ley PB, Roberts JW, Symmonds RE Jr, Hendricks JC, Snyder SK, Frazee RC, Smith RW, McKenney JF, Brindley GV Jr. Safety and efficacy of total thyroidectomy for differentiated thyroid carcinoma: a 20-year review. Am Surg. 1993;59:110–4.

    CAS  PubMed  Google Scholar 

  265. Pacini F, Elisei R, Capezzone M, Miccoli P, Molinaro E, Basolo F, Agate L, Bottici V, Raffaelli M, Pinchera A. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid. 2001;11:877–81.

    CAS  PubMed  Google Scholar 

  266. Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery. 1998;124:958–66.

    CAS  PubMed  Google Scholar 

  267. Flynn MB, Lyons KJ, Tarter JW, Ragsdale TL. Local complications after surgical resection for thyroid carcinoma. Am J Surg. 1994;168:404–7.

    CAS  PubMed  Google Scholar 

  268. Pisanu A, Piu S, Cois A, Uccheddu A. Hypocalcemia following total thyroidectomy: early factors predicting long-term outcome. G Chir. 2005;26:131–4.

    CAS  PubMed  Google Scholar 

  269. Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in lower high-risk papillary thyroid cancer. Ann Surg Oncol. 2005;12:81–9.

    PubMed  Google Scholar 

  270. Mirallié E, Visset J, Sagan C, Hamy A, Le Bodic MF, Paineau J. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg. 1999;23:970–3.

    PubMed  Google Scholar 

  271. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414–24.

    CAS  PubMed  Google Scholar 

  272. Akslen LA. Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer. 1993;72:2680–5.

    CAS  PubMed  Google Scholar 

  273. Akslen LA, Haldorsen T, Thoresen SO, Glattre E. Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Cancer Res. 1991;51:1234–41.

    CAS  PubMed  Google Scholar 

  274. Gemsenjäger E, Perren A, Seifert B, Schüler G, Schweizer I, Heitz PU. Lymph node surgery in papillary thyroid carcinoma. J Am Coll Surg. 2003;197:182–90.

    PubMed  Google Scholar 

  275. Tisell LE. Role of lymphadenectomy in the treatment of differentiated thyroid carcinomas. Br J Surg. 1998;85:1025–6.

    CAS  PubMed  Google Scholar 

  276. Tisell LE, Nilsson B, Mölne J, Hansson G, Fjälling M, Jansson S, Wingren U. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg. 1996;20:854–9.

    CAS  PubMed  Google Scholar 

  277. Sanders EM Jr, LiVolsi VA, Brierley J, Shin J, Randolph GW. An evidence-based review of poorly differentiated thyroid cancer. World J Surg. 2007;31:934–45.

    PubMed  Google Scholar 

  278. Kim JH, Leeper RD. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer. 1987;60:2372–5.

    CAS  PubMed  Google Scholar 

  279. Cooper DS, Schneyer CR. Follicular and Hürthle cell carcinoma of the thyroid. Endocrinol Metab Clin North Am. 1990;19:577–91.

    CAS  PubMed  Google Scholar 

  280. Leeper RD. The effect of 131I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma. J Clin Endocrinol Metab. 1973;36:1143–52.

    CAS  PubMed  Google Scholar 

  281. Beierwaltes WH, Nishiyama RH, Thompson NW, Copp JE, Kubo A. Survival time and “cure” in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med. 1982;23:561–8.

    CAS  PubMed  Google Scholar 

  282. Bernier MO, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F, Enkaoua E, Turpin G, Chiras J, Saillant G, Hejblum G. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2001;86:1568–73.

    CAS  PubMed  Google Scholar 

  283. Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007;110:1451–6.

    PubMed  Google Scholar 

  284. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892–9.

    CAS  PubMed  Google Scholar 

  285. Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001;130:971–7.

    CAS  PubMed  Google Scholar 

  286. Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol. 2002;178:699–704.

    CAS  PubMed  Google Scholar 

  287. Eustatia-Rutten CF, Romijn JA, Guijt MJ, Vielvoye GJ, van den Berg R, Corssmit EP, Pereira AM, Smit JW. Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2003;88:3184–9.

    CAS  PubMed  Google Scholar 

  288. Ronga G, Filesi M, Montesano T, Di Nicola AD, Pace C, Travascio L, et al. Lung metastases from differentiated thyroid carcinoma. A 40 years’ experience. Q J Nucl Med Mol Imaging. 2004;48:12–9.

    CAS  PubMed  Google Scholar 

  289. Lin JD, Chao TC, Chou SC, Hsueh C. Papillary thyroid carcinomas with lung metastases. Thyroid. 2004;14:1091–6.

    PubMed  Google Scholar 

  290. Shoup M, Stojadinovic A, Nissan A, Ghossein RA, Freedman S, Brennan MF, Shah JP, Shaha AR. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg. 2003;197:191–7.

    PubMed  Google Scholar 

  291. Zettinig G, Fueger BJ, Passler C, Kaserer K, Pirich C, Dudczak R, Niederle B. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma—surgery or conventional therapy? Clin Endocrinol (Oxf). 2002;56:377–82.

    Google Scholar 

  292. Pittas AG, Adler M, Fazzari M, Tickoo S, Rosai J, Larson SM, Robbins RJ. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid. 2000;10:261268.

    Google Scholar 

  293. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med. 1996;37:598–605.

    CAS  PubMed  Google Scholar 

  294. Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab. 1995;80:2041–5.

    CAS  PubMed  Google Scholar 

  295. Foote RL, Brown PD, Garces YI, McIver B, Kasperbauer JL. Is there a role for radiation therapy in the management of Hürthle cell carcinoma? Int J Radiat Oncol Biol Phys. 2003;56:1067–72.

    PubMed  Google Scholar 

  296. Pak H, Gourgiotis L, Chang WI, Guthrie LC, Skarulis MC, Reynolds JC, et al. Role of metastasectomy in the management of thyroid carcinoma: the NIH experience. J Surg Oncol. 2003;82:10–8.

    PubMed  Google Scholar 

  297. Vitale G, Fonderico F, Martignetti A, Caraglia M, Ciccarelli A, Nuzzo V, Abbruzzese A, Lupoli G. Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. Br J Cancer. 2001;84:1586–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  298. Kitamura Y, Shimizu K, Nagahama M, Sugino K, Ozaki O, Mimura T, Ito K, Ito K, Tanaka S. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab. 1999;84:4043–9.

    CAS  PubMed  Google Scholar 

  299. Brose MS, Smit J, Capdevila J, Elisei R, Nutting C, Pitoia F, Robinson B, Schlumberger M, Shong YK, Takami H. Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma. Expert Rev Anticancer Ther. 2012;12:1137–47.

    CAS  PubMed  Google Scholar 

  300. Sabra MM, Dominguez JM, Grewal RK, Larson SM, Ghossein RA, Tuttle RM, Fagin JA. Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases. J Clin Endocrinol Metab. 2013;98:E829–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  301. Benua RS, Cicale NR, Sonenberg M, Rawson RW. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol Radium Ther Nucl Med. 1962;87:171–82.

    CAS  PubMed  Google Scholar 

  302. Ilgan S, Karacalioglu AO, Pabuscu Y, Atac GK, Arslan N, Ozturk E, Gunalp B, Ozguven MA. Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2004;31:825–30.

    CAS  PubMed  Google Scholar 

  303. Hod N, Hagag P, Baumer M, Sandbank J, Horne T. Differentiated thyroid carcinoma in children and young adults: evaluation of response to treatment. Clin Nucl Med. 2005;30:387–90.

    PubMed  Google Scholar 

  304. Chiu AC, Delpassand ES, Sherman SI. Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab. 1997;82:3637–42.

    CAS  PubMed  Google Scholar 

  305. McWilliams RR, Giannini C, Hay ID, Atkinson JL, Stafford SL, Buckner JC. Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years. Cancer. 2003;98:356–62.

    PubMed  Google Scholar 

  306. Henriques de Figueiredo B, Godbert Y, Soubeyran I, Carrat X, Lagarde P, et al. Brain metastases from thyroid carcinoma: a retrospective study of 21 patients. Thyroid. 2014;24:270–6.

    PubMed  Google Scholar 

  307. Sabel MS, Staren ED, Gianakakis L, et al. Use of fine needle aspiration biopsy and frozen section in the managementof the solitary thyroid nodule. Surgery. 1997;122:1021–7.

    CAS  PubMed  Google Scholar 

  308. Newman KD, Black T, Heller G, Azizkhan RG, Holcomb GW III, Sklar C, et al. Differentiated thyroid cancer: determinants of disease progression in patients. Ann Surg. 1998;227(4):533–5341.

    CAS  PubMed  PubMed Central  Google Scholar 

  309. Millman B, Pellitteri PK. Nodular thyroid disease in children and adolescents. Otolaryngol Head Neck Surg. 1997;116(6 Pt 1):604–9.

    CAS  PubMed  Google Scholar 

  310. Yang GC, Liebeskind D, Messina AV. Should cytopathologists stop reporting follicular neoplasms on fine-needle aspiration of the thyroid? Cancer. 2003;99:69–74.

    PubMed  Google Scholar 

  311. De Micco C, Vasko V, Garcia S, Zoro P, Denizot A, Henry JF. Fine-needle aspiration of thyroid follicular neoplasm: diagnostic use of thyroid peroxidase immunocytochemistry with monoclonal antibody 47. Surgery. 1994;116:1031–5.

    PubMed  Google Scholar 

  312. Mackinnon WB, Delbridge L, Russell P, et al. Two-dimensional proton magnetic resonance spectroscopy for tissue characterization of thyroid neoplasms. World J Surg. 1996;20:841–7.

    CAS  PubMed  Google Scholar 

  313. Finley DJ, Zhu B, Barden CB, Fahey TJ III. Discrimination of benign and malignant thyroid nodules by molecular profiling. Ann Surg. 2004;240:425–36.

    PubMed  PubMed Central  Google Scholar 

  314. Finley DJ, Lubitz CC, Wei C, Zhu B, Fahey TJ. Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling. Thyroid. 2005;15:562–8.

    CAS  PubMed  Google Scholar 

  315. Shimizu K. Minimally invasive thyroid surgery. Best Pract Res Clin Endocrinol Metab. 2001;15:123–37.

    CAS  PubMed  Google Scholar 

  316. Miccoli P, Berti P, Materazzi G, Minuto M, Barellini L. Minimally invasive video-assisted thyroidectomy: five years of experience. J Am Coll Surg. 2004;199:243–8.

    PubMed  Google Scholar 

  317. Gosnell JE, Sackett WR, Sidhu S, Sywak M, Reeve TS, Delbridge LW. Minimal access thyroid surgery: technique and report of the first 25 cases. ANZ J Surg. 2004;74:330–4.

    PubMed  Google Scholar 

  318. Palazzo FF, Sywak MS, Sidhu SB, Delbridge LW. Safety and feasibility of thyroid lobectomy via a lateral 2.5-cm incision with a cohort comparison of the first 50 cases: evolution of a surgical approach. Langenbecks Arch Surg. 2005;390:230–5.

    PubMed  Google Scholar 

  319. Singer PA, Cooper DS, Daniels GH, et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med. 1996;156:2165–72.

    CAS  PubMed  Google Scholar 

  320. Fagin JA. Molecular defects in thyroid gland neoplasis. J Clin Endocrinol Metab. 1992;75:1398–400.

    CAS  PubMed  Google Scholar 

  321. Learoyd DL, Messina M, Zedenius J, Robinson BG. Molecular genetics of thyroid tumors and surgical decision-making. World J Surg. 2000;24:923–33.

    CAS  PubMed  Google Scholar 

  322. Yeh JJ, Marsh DJ, Zedenius J, Dwight T, Robinson BG, Eng C. Fine structure deletion analysis of 10q22–24 demonstrates regions of loss and suggests that sporadic follicular adenomas and follicular thyroid adenomas develop along distinct parallel neoplastic pathways. Genes Chromosomes Cancer. 1999;26:322–8.

    CAS  PubMed  Google Scholar 

  323. Barden CB, Shister KW, Zhu B, et al. Classification of follicular thyroid tumours by molecular signature: results of gene profiling. Clin Cancer Res. 2003;9:1792–800.

    CAS  PubMed  Google Scholar 

  324. Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676–90.

    Google Scholar 

  325. Papini E, Guglielmi R, Bizzarri G, et al. Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid. 2007;17:229–35.

    CAS  PubMed  Google Scholar 

  326. Hoofnagle AN, Roth MY. Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry. J Clin Endocrinol Metab. 2013;98:1343–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  327. Momesso DP, Tuttle RM. Update on differentiated thyroid cancer staging. Endocrinol Metab Clin North Am. 2014;43:401–21.

    PubMed  Google Scholar 

  328. Vaisman A, Orlov S, Yip J, Hu C, Lim T, Dowar M, Freeman JL, Walfish PG. Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma. Head Neck. 2010;32:689–98.

    PubMed  Google Scholar 

  329. Goldfarb M, Casillas J. Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients. J Cancer Surviv. 2014;8:394–401.

    PubMed  Google Scholar 

  330. Banach R, Bartes B, Farnell K, Rimmele H, Shey J, Singer S, Verburg FA, Luster M. Results of the Thyroid Cancer Alliance international patient/survivor survey: psychosocial/informational support needs, treatment side effects and international differences in care. Hormones (Athens). 2013;12:428–38.

    Google Scholar 

  331. O’Brien MA, Whelan TJ, Villasis-Keever M, Gafni A, Charles C, Roberts R, Schiff S, Cai W. Are cancer-related decision aids effective? A systematic review and meta-analysis. J Clin Oncol. 2009;27:974–85.

    PubMed  Google Scholar 

  332. Spiegle G, Al-Sukhni E, Schmocker S, Gagliardi AR, Victor JC, Baxter NN, Kennedy ED. Patient decision aids for cancer treatment: are there any alternatives? Cancer. 2013;119:189–200.

    PubMed  Google Scholar 

  333. Sawka AM, Straus S, Rotstein L, Brierley JD, Tsang RW, Asa S, Segal P, Kelly C, Zahedi A, Freeman J, Solomon P, Anderson J, Thorpe KE, Gafni A, Rodin G, Goldstein DP. Randomized controlled trial of a computerized decision aid on adjuvant radioactive iodine treatment for patients with early-stage papillary thyroid cancer. J Clin Oncol. 2012;30:2906–11.

    PubMed  Google Scholar 

  334. Spencer CA. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab. 2011;96:3615–27.

    CAS  PubMed  Google Scholar 

  335. Spencer C, Petrovic I, Fatemi S. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab. 2011;96:1283–91.

    CAS  PubMed  Google Scholar 

  336. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, et al. Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg. 2005;29:917–20.

    PubMed  Google Scholar 

  337. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg. 2006;30:91–9.

    PubMed  Google Scholar 

  338. Rothenberg SM, McFadden DG, Palmer EL, Daniels GH, Wirth LJ. Redifferentiation of iodine-refractory BRAFV600E-mutant metastatic papillary thyroid cancer with dabrafenib. Clin Cancer Res. 2015;21:1028–35.

    CAS  PubMed  Google Scholar 

  339. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  340. Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366:2455–65.

    CAS  PubMed  PubMed Central  Google Scholar 

  341. Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med. 2013;369:134–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  342. Husson O, Haak HR, Mols F, Nieuwenhuijzen GA, Nieuwlaat WA, Reemst PH, et al. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncol. 2013;52:447–54.

    PubMed  Google Scholar 

  343. Sawka AM, Naeem A, Jones J, Lowe J, Segal P, Goguen J, et al. Persistent posttreatment fatigue in thyroid cancer survivors: a scoping review. Endocrinol Metab Clin North Am. 2014;43:475–94.

    PubMed  Google Scholar 

  344. To J, Goldberg AS, Jones J, Zhang J, Lowe J, Ezzat S, Gilbert J, Zahedi A, Segal P, Sawka AM. A systematic review of randomized controlled trials for management of persistent post-treatment fatigue in thyroid cancer survivors. Thyroid. 2014;25:198–210.

    PubMed  Google Scholar 

  345. Loh KC. Familial nonmedullary thyroid carcinoma: A meta-review of case series. Thyroid. 1997;7:107–13.

    CAS  PubMed  Google Scholar 

  346. Bresner L, Banach R, Rodin G, Thabane L, Ezzat S, Sawka AM. Cancer-related worry in Canadian thyroid cancer survivors. J Clin Endocrinol Metab. 2015;100:977–85.

    CAS  PubMed  Google Scholar 

  347. Raval MV, Browne M, Chin AC, et al. Total thyroidectomy for benign disease in the pediatric patient--feasible and safe. J Pediatr Surg. 2009;44(8):1529–33.

    PubMed  Google Scholar 

  348. Nguyen GK, Ginsberg J, Crockford PM. Fine needle aspiration biopsy cytology of the thyroid. Its value and limitations in the diagnosis and treatment of solitary thyroid nodules. Pathol Annu. 1991;26(1):63–91.

    PubMed  Google Scholar 

  349. Gharib H, Goeller JR, Zinsmeister AR, Grant CS, Heerden JA. Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings. Ann Intern Med. 1984;101:25–8.

    CAS  PubMed  Google Scholar 

  350. Zingrillo M, Collura D, Ghiggi MR, Nirchio V, Trischitta V. Treatment of large cold benign thyroid nodules not eligible for surgery with percutaneous ethanol injection. J Clin Endocrinol Metab. 1998;83:3905–7.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Alexandria, Alexandria, Egypt

    Mahmoud F. Sakr

Authors
  1. Mahmoud F. Sakr
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sakr, M.F. (2020). Solitary Thyroid Nodule. In: Thyroid Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-48775-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-48775-1_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-48774-4

  • Online ISBN: 978-3-030-48775-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation